NZ233646A - Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions - Google Patents
Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositionsInfo
- Publication number
- NZ233646A NZ233646A NZ23364690A NZ23364690A NZ233646A NZ 233646 A NZ233646 A NZ 233646A NZ 23364690 A NZ23364690 A NZ 23364690A NZ 23364690 A NZ23364690 A NZ 23364690A NZ 233646 A NZ233646 A NZ 233646A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dideoxy
- derivatives
- didehydro
- hydrates
- stable
- Prior art date
Links
- BXZVVICBKDXVGW-NKWVEPMBSA-N Didanosine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(NC=NC2=O)=C2N=C1 BXZVVICBKDXVGW-NKWVEPMBSA-N 0.000 title 1
- 150000004677 hydrates Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 159000000000 sodium salts Chemical class 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35206589A | 1989-05-15 | 1989-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ233646A true NZ233646A (en) | 1991-10-25 |
Family
ID=23383649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ23364690A NZ233646A (en) | 1989-05-15 | 1990-05-11 | Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JP2926257B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2016765C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ9602347A3 (cg-RX-API-DMAC7.html) |
| DD (1) | DD298406A5 (cg-RX-API-DMAC7.html) |
| MY (1) | MY116824A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ233646A (cg-RX-API-DMAC7.html) |
| PL (1) | PL163999B1 (cg-RX-API-DMAC7.html) |
| SK (2) | SK279130B6 (cg-RX-API-DMAC7.html) |
| TW (1) | TW233301B (cg-RX-API-DMAC7.html) |
| YU (1) | YU92890A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA903662B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122207B2 (en) | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
| JP4731121B2 (ja) * | 2004-02-02 | 2011-07-20 | 協和発酵キリン株式会社 | キサンチン誘導体水和物 |
| WO2009119785A1 (ja) * | 2008-03-28 | 2009-10-01 | 浜理薬品工業株式会社 | エチニルチミジン化合物の精製方法 |
| JP5485140B2 (ja) * | 2008-04-10 | 2014-05-07 | 浜理薬品工業株式会社 | ５−メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法 |
-
1990
- 1990-05-11 NZ NZ23364690A patent/NZ233646A/xx unknown
- 1990-05-11 YU YU92890A patent/YU92890A/sh unknown
- 1990-05-12 TW TW79103864A patent/TW233301B/zh active
- 1990-05-14 CA CA002016765A patent/CA2016765C/en not_active Expired - Fee Related
- 1990-05-14 ZA ZA903662A patent/ZA903662B/xx unknown
- 1990-05-14 MY MYPI90000768A patent/MY116824A/en unknown
- 1990-05-14 PL PL28517590A patent/PL163999B1/pl not_active IP Right Cessation
- 1990-05-15 SK SK2372-90A patent/SK279130B6/sk unknown
- 1990-05-15 JP JP12326390A patent/JP2926257B2/ja not_active Expired - Lifetime
- 1990-05-15 DD DD90340679A patent/DD298406A5/de unknown
-
1996
- 1996-08-08 CZ CZ19962347A patent/CZ9602347A3/cs not_active IP Right Cessation
-
1997
- 1997-09-19 SK SK1273-97A patent/SK279253B6/sk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2926257B2 (ja) | 1999-07-28 |
| CA2016765A1 (en) | 1990-11-15 |
| CA2016765C (en) | 1997-10-21 |
| SK127397A3 (en) | 1998-08-05 |
| TW233301B (cg-RX-API-DMAC7.html) | 1994-11-01 |
| PL285175A1 (en) | 1991-01-14 |
| PL163999B1 (pl) | 1994-06-30 |
| YU92890A (sh) | 1992-09-07 |
| CZ288463B6 (en) | 2001-06-13 |
| SK279253B6 (sk) | 1998-08-05 |
| JPH035477A (ja) | 1991-01-11 |
| DD298406A5 (de) | 1992-02-20 |
| CZ9602347A3 (en) | 2001-06-13 |
| SK237290A3 (en) | 1998-07-08 |
| SK279130B6 (sk) | 1998-07-08 |
| MY116824A (en) | 2004-04-30 |
| ZA903662B (en) | 1991-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ226923A (en) | 5'-deoxy-5-fluorocytidine derivatives and pharmaceutical compositions | |
| GR3026225T3 (en) | Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents | |
| IL128504A (en) | 2-HETEROARYL-N-PHENYL (ALKYL) THIENO [2,3-d] PYRIMIDIN-4-AMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| HUP0103641A3 (en) | Antiviral purine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0003355A3 (en) | Thieno[2,3-d]pyrimidinedione derivatives and pharmaceutical compositions containing them, process for their preparation and use thereof | |
| HUT49366A (en) | Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same | |
| FI891338L (fi) | Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi | |
| NZ230144A (en) | Phosphorus-substituted purine derivatives and pharmaceutical compositions | |
| NZ227663A (en) | Purine nucleoside analogues, pyrimidine derivatives and pharmaceutical compositions | |
| IL92293A0 (en) | 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives and pharmaceutical compositions containing them | |
| ZA907256B (en) | Low sodium salt composition | |
| NZ224189A (en) | 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions | |
| JPS57144298A (en) | 7-beta-d-arabinofuranosyl-7h- pyrrolo(2,3-d)pyrimidine compound and manufacture | |
| IL66471A (en) | 9'-thiaergotaman-3',6',18-trione derivatives,their preparation and pharmaceutical compositions containing them | |
| IL95870A0 (en) | Purine nucleoside derivatives,their preparation and pharmaceutical compositions containing them | |
| IL92587A0 (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition | |
| IL98812A0 (en) | Purine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| NZ233646A (en) | Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions | |
| AU633065B2 (en) | 3'-substituted methyl nucleosides as antiviral agents | |
| NZ219971A (en) | Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions | |
| IL97656A0 (en) | Purine derivatives,process for their preparation and pharmaceutical compositions comprising them | |
| NZ216054A (en) | Thieno (2,3-d)imidazole derivatives and pharmaceutical compositions | |
| IL95527A0 (en) | Pyrimidinedione derivatives,their preparation and anthelmintic compositions containing them | |
| IL74803A0 (en) | Purine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL94485A0 (en) | Purine derivatives,process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |